BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 17786225)

  • 1. Deletion of the N-terminus of SF2/ASF permits RS-domain-independent pre-mRNA splicing.
    Shaw SD; Chakrabarti S; Ghosh G; Krainer AR
    PLoS One; 2007 Sep; 2(9):e854. PubMed ID: 17786225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-mRNA splicing in the absence of an SR protein RS domain.
    Zhu J; Krainer AR
    Genes Dev; 2000 Dec; 14(24):3166-78. PubMed ID: 11124808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic analysis of the SR protein ASF/SF2: interchangeability of RS domains and negative control of splicing.
    Wang J; Xiao SH; Manley JL
    Genes Dev; 1998 Jul; 12(14):2222-33. PubMed ID: 9679066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substrate specificities of SR proteins in constitutive splicing are determined by their RNA recognition motifs and composite pre-mRNA exonic elements.
    Mayeda A; Screaton GR; Chandler SD; Fu XD; Krainer AR
    Mol Cell Biol; 1999 Mar; 19(3):1853-63. PubMed ID: 10022872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for the function of an exonic splicing enhancer after the first catalytic step of pre-mRNA splicing.
    Chew SL; Liu HX; Mayeda A; Krainer AR
    Proc Natl Acad Sci U S A; 1999 Sep; 96(19):10655-60. PubMed ID: 10485881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The second RNA-binding domain of the human splicing factor ASF/SF2 is the critical domain controlling adenovirus E1A alternative 5'-splice site selection.
    Dauksaite V; Akusjärvi G
    Biochem J; 2004 Jul; 381(Pt 2):343-50. PubMed ID: 15068396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regiospecific phosphorylation control of the SR protein ASF/SF2 by SRPK1.
    Ma CT; Hagopian JC; Ghosh G; Fu XD; Adams JA
    J Mol Biol; 2009 Jul; 390(4):618-34. PubMed ID: 19477182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of SRp20 exon 4 splicing.
    Jumaa H; Nielsen PJ
    Biochim Biophys Acta; 2000 Nov; 1494(1-2):137-43. PubMed ID: 11072076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exonic splicing enhancer-dependent selection of the bovine papillomavirus type 1 nucleotide 3225 3' splice site can be rescued in a cell lacking splicing factor ASF/SF2 through activation of the phosphatidylinositol 3-kinase/Akt pathway.
    Liu X; Mayeda A; Tao M; Zheng ZM
    J Virol; 2003 Feb; 77(3):2105-15. PubMed ID: 12525645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional analysis of pre-mRNA splicing factor SF2/ASF structural domains.
    Cáceres JF; Krainer AR
    EMBO J; 1993 Dec; 12(12):4715-26. PubMed ID: 8223480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SR proteins Asf/SF2 and 9G8 interact to activate enhancer-dependent intron D splicing of bovine growth hormone pre-mRNA in vitro.
    Li X; Shambaugh ME; Rottman FM; Bokar JA
    RNA; 2000 Dec; 6(12):1847-58. PubMed ID: 11142383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of a PKCI-1-related mRNA is controlled by the splicing factor ASF/SF2: a novel function for SR proteins.
    Lemaire R; Prasad J; Kashima T; Gustafson J; Manley JL; Lafyatis R
    Genes Dev; 2002 Mar; 16(5):594-607. PubMed ID: 11877379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SF2/ASF binds to a splicing enhancer in the third HIV-1 tat exon and stimulates U2AF binding independently of the RS domain.
    Tange TØ; Kjems J
    J Mol Biol; 2001 Sep; 312(4):649-62. PubMed ID: 11575921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human splicing factor ASF/SF2 encodes for a repressor domain required for its inhibitory activity on pre-mRNA splicing.
    Dauksaite V; Akusjärvi G
    J Biol Chem; 2002 Apr; 277(15):12579-86. PubMed ID: 11801589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA splicing specificity determined by the coordinated action of RNA recognition motifs in SR proteins.
    Chandler SD; Mayeda A; Yeakley JM; Krainer AR; Fu XD
    Proc Natl Acad Sci U S A; 1997 Apr; 94(8):3596-601. PubMed ID: 9108022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arginine/serine-rich protein interaction domain-dependent modulation of a tau exon 10 splicing enhancer: altered interactions and mechanisms for functionally antagonistic FTDP-17 mutations Delta280K AND N279K.
    D'Souza I; Schellenberg GD
    J Biol Chem; 2006 Feb; 281(5):2460-9. PubMed ID: 16308321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of the SR proteins ASF/SF2 and SC35 influences alternative splicing in vivo in diverse ways.
    Wang J; Manley JL
    RNA; 1995 May; 1(3):335-46. PubMed ID: 7489505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of dephosphorylation of the SR protein ASF/SF2 by protein phosphatase 1.
    Ma CT; Ghosh G; Fu XD; Adams JA
    J Mol Biol; 2010 Oct; 403(3):386-404. PubMed ID: 20826166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of the ASF/SF2 RS domain affects both protein-protein and protein-RNA interactions and is necessary for splicing.
    Xiao SH; Manley JL
    Genes Dev; 1997 Feb; 11(3):334-44. PubMed ID: 9030686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping the SF2/ASF binding sites in the bovine growth hormone exonic splicing enhancer.
    Dirksen WP; Li X; Mayeda A; Krainer AR; Rottman FM
    J Biol Chem; 2000 Sep; 275(37):29170-7. PubMed ID: 10880506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.